| 摘要 |
<p>Drugs useful in preventing and treating type 2 diabetes. Namely, drugs for improving insulin resistance which comprise as the active ingredient N-[(2-morpholinyl)methyl]benzamide derivatives represented by the following general formula (I), stereoisomers thereof or physiologically acceptable acid addition salts of the same: (I) wherein R represents hydrogen or 4-fluorobenzyl.</p> |
